Table 2.
Percentage of silent, truncating and functional mutations affecting genes with one copy loss.
| Cancer | silent mutation | truncating mutation | P-value | all missense mutations | Missense mutations selected by FIS | ||||
|---|---|---|---|---|---|---|---|---|---|
| FIS>2 | FIS>2.5 | FIS>3.0 | FIS>3.5 | P-val | |||||
| breast | 11.6 | 16.7 | 0 | 12.5 | 12.9 | 13.4 | 14.2 | 16.3 | 2E-06 |
| lung | 11.4 | 13.5 | 2E-05 | 11.7 | 12.1 | 12.4 | 12.5 | 12.5 | 0.009 |
| colon | 10.7 | 13.6 | 0.001 | 11.5 | 12.4 | 13.3 | 14.2 | 15.2 | 3E-04 |
| kidney | 6.1 | 14.3 | 0 | 6.5 | 11.3 | 12.1 | 11.4 | 10.9 | 2E-04 |
| brain | 12.5 | 15.3 | 9E-06 | 13.9 | 14.1 | 14.6 | 15.0 | 14.6 | 0.009 |
| overian | 20.5 | 30 | 0 | 22.3 | 23.6 | 26.2 | 26.0 | 29.0 | 0 |
Predicted high-scoring functional missense mutations tend to be selected in genes with one copy loss practically as frequent as truncating mutations.